Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | PAM | P19021 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5580493 | 1.00 | MGLL (0.53) | MGLLCA1HDAC2ALDH1A1CYP3A4 | |
| Biphenyl SCHEMBL21402589 | 0.93 | PAM (0.52) | MGLLCA1HDAC2ALDH1A1CYP3A4 | |
| Biphenyl SCHEMBL21402588 | 0.93 | PAM (0.52) | MGLLCA1HDAC2ALDH1A1CYP3A4 | |
| Cinnamic Alcohol SCHEMBL27887623 | 0.86 | PAM (0.58) | CA1HDAC2ALDH1A1CYP3A4RECQL | |
| Cinnamic Alcohol SCHEMBL39220 | 0.86 | PAM (0.58) | CA1HDAC2ALDH1A1CYP3A4RECQL | |
| Cinnamic Alcohol SCHEMBL891462 | 0.86 | PAM (0.58) | CA1HDAC2ALDH1A1CYP3A4RECQL | |
| Cinnamic Alcohol SCHEMBL28583889 | 0.86 | PAM (0.58) | CA1HDAC2ALDH1A1CYP3A4RECQL | |
| Cinnamic Alcohol SCHEMBL4175503 | 0.86 | PAM (0.58) | CA1HDAC2ALDH1A1CYP3A4RECQL | |
| Cinnamic Alcohol SCHEMBL39219 | 0.86 | PAM (0.58) | CA1HDAC2ALDH1A1CYP3A4RECQL | |
| Cinnamic Alcohol SCHEMBL28671087 | 0.84 | PAM (0.56) | CA1HDAC2ALDH1A1CYP3A4RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113135816-A | Method for synthesizing photoactive bromohydrin compound | 常州大学 | 2021-07-20 | — | — | CN | disclosed |
| CN-108947754-B | Use of bidentate phosphite ligands in C-F bond building reactions | 郑州大学 | 2021-02-26 | — | — | CN | disclosed |
| US-10202410-B2 | Scaphopetalone analogs and their uses | BRIGHAM YOUNG UNIVERSITY (US) | 2019-02-12 | — | — | US | disclosed |
| US-20170152280-A1 | SCAPHOPETALONE ANALOGS AND THEIR USES | BRIGHAM YOUNG UNIVERSITY | 2017-06-01 | — | — | US | disclosed |
| US-20170152280-A1 | SCAPHOPETALONE ANALOGS AND THEIR USES | BRIGHAM YOUNG UNIVERSITY | 2017-06-01 | — | — | US | disclosed |
| US-20170107180-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | MERCK SHARP & DOHME CORP. | 2017-04-20 | — | — | US | disclosed |
| US-20150299122-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC. (CA) | 2015-10-22 | — | — | US | disclosed |
| US-20070105959-A1 | Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| US-7067530-B2 | Compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2006-06-27 | — | — | US | disclosed |
| EP-1604971-A1 | CINNAMYL ALCOHOL DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-12-14 | — | — | EP | disclosed |
| US-6867218-B2 | Compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2005-03-15 | — | — | US | disclosed |
| US-20030195200-A1 | Compounds, their preparation and use | VTVX HOLDINGS II LLC | 2003-10-16 | — | — | US | disclosed |
| US-20030109560-A1 | Novel compounds, their preparation and use | HIGH POINT PHARMACEUTICALS, LLC | 2003-06-12 | — | — | US | disclosed |
| US-6555577-B1 | For treatment and/or prevention of conditions mediated by the Peroxisome Proliferator-Activated Receptors (PPAR), such as diabetes and/or obesity; 3-(4-(3-Biphenyl-4-yl-but-2-enyloxy)-phenyl)-2-butoxy-propionic acid for example | NOVO NORDISK A/S (DE) | 2003-04-29 | — | — | US | disclosed |
| EP-1254101-A1 | PROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF DIABETES AND OBESITY | Novo Nordisk A/S (DK) | 2002-11-06 | — | — | EP | disclosed |
| WO-2001055085-A1 | PROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF DIABETES AND OBESITY | NOVO NORDISK A/S (DK) | 2001-08-02 | — | — | WO | disclosed |
| US-3995054-A | MITICIDES | ZOECON CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10202410-B2 | Scaphopetalone analogs and their uses | MUSK, SHBG, CYP17A1 | MGLL 1181/4885CA1 4412/4885HDAC2 4603/4885 |
| US-20150299122-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | OGA, ENGASE, OGT | MGLL 900/4885CA1 1702/4885HDAC2 388/4885 |
| US-20070105959-A1 | Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient | LPL, GPR119, EBP | MGLL 39/4885CA1 4800/4885HDAC2 444/4885 |
| US-20030195200-A1 | Compounds, their preparation and use | PPARG, PPARA, PPARD | MGLL 862/4885CA1 4184/4885HDAC2 1111/4885 |
| US-20170152280-A1 | SCAPHOPETALONE ANALOGS AND THEIR USES | MUSK, SHBG, CYP17A1 | MGLL 1181/4885CA1 4412/4885HDAC2 4603/4885 |
| US-20170107180-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | OGA, ENGASE, OGT | MGLL 900/4885CA1 1702/4885HDAC2 388/4885 |
| US-20030109560-A1 | Novel compounds, their preparation and use | PPARG, PPARD, PPARA | MGLL 792/4885CA1 4613/4885HDAC2 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.